Article
Real life data and outcome of FOLFIRINOX use in metastatic pancreatic cancer patients in general hospitals in the Netherlands
2023-11-15
Abstract excerpt
<h4>Introduction: </h4> Pancreatic cancer is one of the five most common causes of cancer mortality in developed countries. In patients with metastatic disease, the most frequent treatment used is FOLFIRINOX, which is associated with moderate toxicity which could influence quality of life. The efficacy of FOLFIRINOX in a general population in the Netherlands hasn’t been subject of research before and therefore thi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e2d70811-995b-599b-a439-d742641f9da8
- DOI
- 10.21203/rs.3.rs-3595248/v1